[HTML][HTML] Фибрилляция и трепетание предсердий. Клинические рекомендации 2020

МГ Аракелян, ЛА Бокерия, ЕЮ Васильева… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

[HTML][HTML] 2020 Clinical guidelines for Atrial fibrillation and atrial flutter

MG Arakelyan, LA Bockeria… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …

Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic …

R Noviyani, S Youngkong, S Nathisuwan… - BMJ Evidence-Based …, 2022 - ebm.bmj.com
Objectives To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared
with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling …

Genotype-guided warfarin therapy: current status

LC Tavares, LR Marcatto, PCJL Santos - Pharmacogenomics, 2018 - Taylor & Francis
Warfarin pharmacogenomics has been an extensively studied field in the last decades as it
is focused on personalized therapy to overcome the wide interpatient warfarin response …

Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use

M Proietti, I Marzona, T Vannini, M Tettamanti… - Mayo Clinic …, 2019 - Elsevier
Objectives To analyze the relationship between atrial fibrillation (AF) and Charlson
comorbidity index (CCI) in a population-based cohort study over a long-term follow-up …

Outcomes of patients with a mechanical heart valve and poor anticoagulation control on warfarin

I Johansson, AP Benz, T Kovalova… - Thrombosis and …, 2023 - thieme-connect.com
Background Patients with a mechanical heart valve (MHV) require oral anticoagulation. Poor
anticoagulation control is thought to be associated with adverse outcomes, but data are …

Lower versus standard INR targets in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials

AK Pandey, K Xu, L Zhang, S Gupta… - Thrombosis and …, 2020 - thieme-connect.com
Background Western guidelines recommend an international normalized ratio (INR) range
of 2 to 3 when using warfarin for stroke prevention in atrial fibrillation (AF), but lower INR …

Warfarin adherence and anticoagulation control in atrial fibrillation patients: a systematic review.

M Ababneh, SA Nasser, A Rababa'h… - European Review for …, 2021 - search.ebscohost.com
OBJECTIVE: This paper aims to review the literature systematically on warfarin adherence in
patients with atrial fibrillation and to assess the anticoagulation control focused on patient …

Anticoagulation for atrial fibrillation: a review of current literature and views

C Jin, C Cui, M Seplowe, KI Lee, R Vegunta… - Cardiology in …, 2024 - journals.lww.com
Atrial fibrillation is a common supraventricular tachyarrhythmia with uncoordinated atrial
activation and ineffective atrial contraction. This leads to an increased risk of atrial thrombi …

The quality of anticoagulation therapy among warfarin-treated patients with atrial fibrillation in a primary health care setting

G Urbonas, L Valius, G Šakalytė, K Petniūnas… - Medicina, 2019 - mdpi.com
Background and objectives: Long-term therapy with oral anticoagulants is recommended for
stroke prevention in patients with atrial fibrillation (AF). This study evaluated the quality of …